PCD

First Commonwealth Announces First Quarter 2024 Earnings; Increases Quarterly Dividend

Retrieved on: 
星期二, 四月 23, 2024

The net interest margin for the first quarter of 2024 was 3.52% as compared to 3.65% in the prior quarter and 4.01% in the year ago quarter.

Key Points: 
  • The net interest margin for the first quarter of 2024 was 3.52% as compared to 3.65% in the prior quarter and 4.01% in the year ago quarter.
  • Provision for credit losses totaled $4.2 million in the first quarter of 2024 as compared to ($1.9) million in the previous quarter.
  • First Commonwealth Financial Corporation declared a common stock quarterly dividend of $0.13 per share, which represents a 4.0% increase from the previous quarter.
  • First Commonwealth will host a quarterly conference call to discuss its financial results for the first quarter of 2024 on Wednesday, April 24, 2024 at 2:00 PM (ET).

Old National Bancorp Reports First Quarter 2024 Results

Retrieved on: 
星期二, 四月 23, 2024

Old National Bancorp (NASDAQ: ONB) reports 1Q24 net income applicable to common shares of $116.3 million, diluted EPS of $0.40; $130.8 million and $0.45 on an adjusted1 basis, respectively.

Key Points: 
  • Old National Bancorp (NASDAQ: ONB) reports 1Q24 net income applicable to common shares of $116.3 million, diluted EPS of $0.40; $130.8 million and $0.45 on an adjusted1 basis, respectively.
  • On April 1, 2024, Old National completed its acquisition of CapStar Financial Holdings, Inc. ("CapStar"), and its wholly-owned subsidiary, CapStar Bank.
  • Old National expects system conversions related to the transaction to be completed in the third quarter of 2024.
  • Old National will host a conference call and live webcast at 9:00 a.m. Central Time on Tuesday, April 23, 2024, to review first quarter financial results.

First Bank Announces First Quarter 2024 Net Income of $12.5 Million

Retrieved on: 
星期一, 四月 22, 2024

Net income for the first quarter of 2024 was $12.5 million, or $0.50 per diluted share, compared to $7.0 million, or $0.36 per diluted share, for the first quarter of 2023.

Key Points: 
  • Net income for the first quarter of 2024 was $12.5 million, or $0.50 per diluted share, compared to $7.0 million, or $0.36 per diluted share, for the first quarter of 2023.
  • In the first quarter of 2024, the Bank recorded non-interest income totaling $2.0 million, compared to $1.0 million during the same period in 2023 and non-interest income measuring $(3.0) million during the fourth quarter of 2023.
  • Non-interest expense for the first quarter of 2024 was $17.8 million, an increase of $4.3 million, or 31.9%, compared to $13.5 million for the prior year quarter.
  • The Bank recorded net recoveries of $202,000 during the first quarter of 2024, excluding the $5.5 million PCD loan charge-off, compared to net charge-offs of $209,000 in the fourth quarter of 2023 and net charge-offs of $315,000 in the first quarter of 2023.

OceanFirst Financial Corp. Announces First Quarter Financial Results

Retrieved on: 
星期四, 四月 18, 2024

Refer to “Explanation of Non-GAAP Financial Measures” and the “Non-GAAP Reconciliation” tables for additional information regarding non-GAAP financial measures.

Key Points: 
  • Refer to “Explanation of Non-GAAP Financial Measures” and the “Non-GAAP Reconciliation” tables for additional information regarding non-GAAP financial measures.
  • Refer to “Explanation of Non-GAAP Financial Measures” and the “Non-GAAP Reconciliation” tables for additional information regarding non-GAAP financial measures.
  • The current quarter results were impacted by the following matters.
  • OceanFirst Financial Corp.’s subsidiary, OceanFirst Bank N.A., founded in 1902, is a $13.4 billion regional bank providing financial services throughout New Jersey and in the major metropolitan markets of Philadelphia, New York, Baltimore, and Boston.

International Medical Industries, Inc. Announces Partnership with Grifols for Enhanced Medication Safety

Retrieved on: 
星期一, 四月 8, 2024

POMPANO BEACH, Fla., April 8, 2024 /PRNewswire/ -- International Medical Industries, Inc. (IMI) is thrilled to announce an innovative partnership with Grifols that promises to enhance medication safety through cutting-edge technology.

Key Points: 
  • POMPANO BEACH, Fla., April 8, 2024 /PRNewswire/ -- International Medical Industries, Inc. (IMI) is thrilled to announce an innovative partnership with Grifols that promises to enhance medication safety through cutting-edge technology.
  • IMI, the industry leader in secure drug delivery devices, is joining forces with Kiro Grifols, dedicated to the state-of-the-art automated pharmacy compounding device (PCD), KIRO Fill.
  • Their commitment to quality and patient safety perfectly aligns with Kiro Grifols' mission to deliver innovative solutions that enhance pharmacy automation and accuracy.
  • This strategic partnership aims to reshape the landscape of pharmaceutical compounding, setting a new benchmark for safety, precision, and reliability.

First Bank Announces Fourth Quarter 2023 Net Income of $8.4 Million and Full Year Net Income of $20.9 Million

Retrieved on: 
星期三, 一月 24, 2024

Net income for the fourth quarter of 2023 was $8.4 million, or $0.33 per diluted share, compared to $9.1 million, or $0.46 per diluted share, for the fourth quarter of 2022.

Key Points: 
  • Net income for the fourth quarter of 2023 was $8.4 million, or $0.33 per diluted share, compared to $9.1 million, or $0.46 per diluted share, for the fourth quarter of 2022.
  • Fourth Quarter and Full Year 2023 Performance Highlights:
    Total net revenue (net interest income plus non-interest income) of $28.0 million for the fourth quarter of 2023 increased $2.8 million, or 11.1%, compared to the prior year quarter, while full year total net revenue was $103.8 million, an increase of $6.3 million, or 6.5%, compared to 2022.
  • Non-interest bearing deposits increased $8.1 million during the fourth quarter of 2023 while interest bearing deposits decreased $7.9 million.
  • The Bank recorded net charge-offs of $209,000 during the fourth quarter of 2023 compared to net charge-offs of $1.1 million in the third quarter of 2023 and net recoveries of $213,000 in the fourth quarter of 2022.

Old National's 4th Quarter and Record Full-Year Results Supported by Strong Deposit Franchise, Stable Credit Quality and Well-Managed Expenses

Retrieved on: 
星期二, 一月 23, 2024

A loan to deposit ratio of 89% at December 31, 2023, combined with existing funding sources, provides strong liquidity.

Key Points: 
  • A loan to deposit ratio of 89% at December 31, 2023, combined with existing funding sources, provides strong liquidity.
  • Total commercial loan production in the fourth quarter was $1.3 billion; period-end commercial pipeline totaled $1.7 billion.
  • Average total loans in the fourth quarter were $32.8 billion, an increase of $116.9 million from the third quarter of 2023.
  • Strong credit quality continues to be a hallmark of Old National.

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

Retrieved on: 
星期四, 一月 18, 2024

1 Core earnings and core earnings before income taxes and provision for credit losses (“PTPP or Pre-Tax-Pre-Provision”), and ratios derived therefrom, are non-GAAP financial measures.

Key Points: 
  • 1 Core earnings and core earnings before income taxes and provision for credit losses (“PTPP or Pre-Tax-Pre-Provision”), and ratios derived therefrom, are non-GAAP financial measures.
  • Refer to “Explanation of Non-GAAP Financial Measures” and the “Non-GAAP Reconciliation” tables for additional information regarding non-GAAP financial measures.
  • Refer to “Explanation of Non-GAAP Financial Measures” and the “Non-GAAP Reconciliation” tables for additional information regarding non-GAAP financial measures.
  • OceanFirst Financial Corp.’s subsidiary, OceanFirst Bank N.A., founded in 1902, is a $13.5 billion regional bank providing financial services throughout New Jersey and in the major metropolitan markets of Philadelphia, New York, Baltimore, and Boston.

ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia

Retrieved on: 
星期三, 一月 3, 2024

“This is the first time a patient with PCD has received a targeted mRNA-based therapeutic,” said Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer of ReCode Therapeutics.

Key Points: 
  • “This is the first time a patient with PCD has received a targeted mRNA-based therapeutic,” said Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer of ReCode Therapeutics.
  • “This study will evaluate RCT1100 as a potential novel treatment option for patients who do not have any approved therapies.
  • The DNAI1 mRNA is intended to establish or restore proper ciliary function by addressing the underlying cause of the disease.
  • This study brings us one step closer to improving the respiratory health and quality of life of people living with this disease.”

TriMas Packaging Group to Exhibit at Paris Packaging Week 2024

Retrieved on: 
星期四, 十二月 28, 2023

TriMas Packaging, the largest division of TriMas (NASDAQ: TRS), will exhibit at Paris Packaging Week 2024 at the Paris Expo Porte de Versailles on January 17-18th.

Key Points: 
  • TriMas Packaging, the largest division of TriMas (NASDAQ: TRS), will exhibit at Paris Packaging Week 2024 at the Paris Expo Porte de Versailles on January 17-18th.
  • TriMas Packaging, and its market-leading brands, consisting of Rieke®, Aarts Packaging, Affaba & Ferrari™, Taplast™ and Rapak®, will be showcasing its most innovative and sustainable product solutions for the beauty and personal care markets.
  • “As the beauty packaging industry continues to evolve, consumers are seeking a more personalized and premium experience,” said Fabio Salik, TriMas Packaging Group President.
  • “The Paris Packaging Week show is the ideal forum for us to present our most innovative and highly customizable offerings in the growing beauty and cosmetic sector.